<?xml version="1.0" encoding="UTF-8"?>
<p id="Par8">More recently, it was observed that the number of 
 <italic>Plasmodium</italic> strains resistant to the drugs available on the market has increased dramatically, and researches for the discovery of new antimalarial drugs have become increasingly necessary. Some emerging countries like Brazil, India, and China have invested extensively in researches for the treatment of neglected tropical diseases, especially malaria. In the 1970s, Chinese researchers presented artemisinin and its semisynthetic derivatives (Artemether, Arteether, Artesunate, Artemisinic acid, and Dihydroartemisin) as potential antimalarial drugs (Li et al. 
 <xref ref-type="bibr" rid="CR52">1998</xref>; Prince 
 <xref ref-type="bibr" rid="CR72">2000</xref>; Haynes 
 <xref ref-type="bibr" rid="CR44">2001</xref>). The success of these drugs in the treatment of malaria is due to the fact that the 
 <italic>Plasmodium</italic> strains have still little or no resistance to them.
</p>
